Skip to main content
Back to Investments

Alanta Health Group

Employees
852
Sites
5
Status
Current
Country
Germany
Strategy
Mid Cap
Entry
Dec-16
Fund
IK VIII

A leading compounder of patient-individual infusions in chemotherapy treatment in Germany

Alanta Health Group (“the Group”), formerly ZytoService, is the largest industrially organised 13 AMG Arzneimittelgeset (“AMG”) certified compounder for patient-individualised infusions applied mainly in oncology treatment in Germany.

The Group is based in Hamburg, where it runs a state-of-the-art compounding facility as well as four further sites across Germany.

The majority stake in the Group was acquired from its founders and capiton in December 2016.

What Attracted us to the Business

  • Strong market position
  • Significant potential to develop further
  • Customer service being ranked highly

Our Value Creation Strategy

We are working alongside management to:

  • Streamline operations and increase process efficiency;
  • Leverage market leading position to increase sales and market penetration; and
  • Pursue further market consolidation via targeted add-ons.

Quote from the Client

“Alanta health group operates in an industry in which IK has extensive expertise.”

Enno Scheel, Co-Founder, Alanta Health Group

Investment Team

Detlef Dinsel

Managing Partner, Head of Partnership Fund Strategy
Hamburg

Anders Petersson

Managing Partner, Healthcare Sector Lead
Hamburg

Nils Pohlmann

Partner
Hamburg

Alexander Dokters

Director
Hamburg